Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial

This study is ongoing, but not recruiting participants.

Sponsored by:	Bispebjerg Hospital
Information provided by:	Bispebjerg Hospital
ClinicalTrials.gov Identifier:	NCT00689650

Purpose

The objective was to evaluate the efficacy of 1540 nm fractional laser treatment of mature burn scars.

Condition	Intervention
Burn Scar Patients	Device: 1540 nm fractional laser

MedlinePlus related topics: Burns Scars

Study Type:	Interventional
Official Title:	Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial

Further study details as provided by Bispebjerg Hospital:

Primary Outcome Measures:

Study Start Date:

November 2007

Arms	Assigned Interventions
A: Experimental	Device: 1540 nm fractional laser
B: No Intervention

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

A tendency to produce hypertrophic scars or keloids,
Previous treatment with dermabrasio, chemical peel, filler, laser treatment or Intense Pulsed Light (IPL) of study areas,
Photosensitivity,
Pregnancy or lactation,
Current anticoagulative medication,
Oral retinoid drugs within the past 6 months,
Pigmentation after recent exposure to sun or solarium,
Patients not considered to be able to follow the treatment protocol.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00689650

Locations

Denmark
Bispebjerg University Hospital
Copenhagen NV, Denmark, 2400

Sponsors and Collaborators

Bispebjerg Hospital

More Information

No publications provided

Study ID Numbers:	H-D-2007-0094
Study First Received:	May 30, 2008
Last Updated:	May 30, 2008
ClinicalTrials.gov Identifier:	NCT00689650
Health Authority:	Denmark: The Ministry of the Interior and Health

Study placed in the following topic categories:

Burns
Skin Diseases
Wounds and Injuries
Disorders of Environmental Origin
Cicatrix

ClinicalTrials.gov processed this record on February 12, 2009